Rohto Pharmaceutical Co., Ltd. (RPHCF)
15.00
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Rohto Pharmaceutical Net Income (Quarterly) : 69.33M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 69.33M |
| March 31, 2026 | 38.73M |
| December 31, 2025 | 68.60M |
| September 30, 2025 | 38.80M |
| June 30, 2025 | 83.37M |
| March 31, 2025 | 39.76M |
| December 31, 2024 | 76.08M |
| September 30, 2024 | 28.98M |
| June 30, 2024 | 54.44M |
| March 31, 2024 | 32.76M |
| December 31, 2023 | 65.63M |
| September 30, 2023 | 52.38M |
| June 30, 2023 | 67.27M |
| March 31, 2023 | 34.70M |
| December 31, 2022 | 60.47M |
| September 30, 2022 | 44.95M |
| June 30, 2022 | 54.41M |
| March 31, 2022 | 34.05M |
| December 31, 2021 | 54.30M |
| September 30, 2021 | 57.08M |
| June 30, 2021 | 43.42M |
| March 31, 2021 | 57.01M |
| December 31, 2020 | 47.05M |
| September 30, 2020 | 38.14M |
| June 30, 2020 | 16.33M |
| Date | Value |
|---|---|
| March 31, 2020 | 24.53M |
| December 31, 2019 | 48.57M |
| September 30, 2019 | 47.56M |
| June 30, 2019 | 20.23M |
| March 31, 2019 | -9.914M |
| December 31, 2018 | 31.70M |
| September 30, 2018 | 34.85M |
| June 30, 2018 | 31.60M |
| March 31, 2018 | -7.073M |
| December 31, 2017 | 39.44M |
| September 30, 2017 | 30.38M |
| June 30, 2017 | 20.51M |
| March 31, 2017 | 14.05M |
| December 31, 2016 | 38.65M |
| September 30, 2016 | 27.51M |
| June 30, 2016 | 12.68M |
| March 31, 2016 | 11.18M |
| December 31, 2015 | 24.12M |
| September 30, 2015 | 29.03M |
| June 30, 2015 | 10.90M |
| March 31, 2015 | 23.32M |
| December 31, 2014 | 19.78M |
| September 30, 2014 | 28.24M |
| June 30, 2014 | 6.357M |
| March 31, 2014 | 7.513M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Kao Corp. | 219.14M |
| Kosé Holdings Corp. | 32.61M |
| euglena Co., Ltd. | 3.357M |
| Milbon Co., Ltd. | 8.79M |
| Mandom Corp. | 3.310M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 574.97M |
| Total Expenses (Quarterly) | 508.13M |
| EPS Diluted (Quarterly) | 0.2918 |
| Enterprise Value | 3.342B |
| Gross Profit Margin (Quarterly) | 55.72% |
| Profit Margin (Quarterly) | 12.06% |
| Earnings Yield | 6.04% |
| Operating Earnings Yield | 7.96% |